Oxford Asset Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-10,336
| Closed | -$326K | – | 1622 |
|
|
2018
Q4 | $326K | Buy |
10,336
+2,611
| +34% | +$82.4K | 0.01% | 1369 |
|
|
2018
Q3 | $466K | Sell |
7,725
-13,454
| -64% | -$812K | 0.01% | 1333 |
|
|
2018
Q2 | $1.13M | Sell |
21,179
-5,902
| -22% | -$315K | 0.02% | 967 |
|
|
2018
Q1 | $1.57M | Buy |
27,081
+23,182
| +595% | +$1.34M | 0.03% | 702 |
|
|
2017
Q4 | $138K | Sell |
3,899
-15,845
| -80% | -$561K | ﹤0.01% | 1498 |
|
|
2017
Q3 | $703K | Sell |
19,744
-3,223
| -14% | -$115K | 0.01% | 1091 |
|
|
2017
Q2 | $574K | Buy |
22,967
+20,163
| +719% | +$504K | 0.01% | 1064 |
|
|
2017
Q1 | $76K | Buy |
2,804
+1,589
| +131% | +$43.1K | ﹤0.01% | 1363 |
|
|
2016
Q4 | $35K | Buy |
+1,215
| New | +$35K | ﹤0.01% | 746 |
|
|
2016
Q3 | – | Sell |
-6,048
| Closed | -$191K | – | 763 |
|
|
2016
Q2 | $191K | Sell |
6,048
-3,871
| -39% | -$122K | 0.01% | 697 |
|
|
2016
Q1 | $513K | Sell |
9,919
-26,359
| -73% | -$1.36M | 0.01% | 610 |
|
|
2015
Q4 | $3.45M | Buy |
+36,278
| New | +$3.45M | 0.08% | 274 |
|